WO2023037254 - METHODS AND COMPOUNDS FOR TREATING CORONAVIRIDAE VIRUS INFECTIONS
National phase entry is expected:
Publication Number
WO/2023/037254
Publication Date
16.03.2023
International Application No.
PCT/IB2022/058395
International Filing Date
07.09.2022
Title **
[English]
METHODS AND COMPOUNDS FOR TREATING CORONAVIRIDAE VIRUS INFECTIONS
[French]
MÉTHODES ET COMPOSÉS POUR LE TRAITEMENT D'INFECTIONS PAR UN VIRUS DE LA FAMILLE DES CORONAVIRIDAE
Applicants **
DIDENKO, Kirill
SM3 M3 L8 01
COND SKY
SUPERMANZANA 3
Cancun, 77500, MX
Inventors
DIDENKO, Kirill
SM3 M3 L8 01
COND SKY
SUPERMANZANA 3
Cancun, 77500, MX
Priority Data
63/241,541
08.09.2021
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| * | |
International Searching Authority |
USPTO
* |
| * | |
| Applicant's Legal Status |
Natural Person
* |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter II
* |
| * | |
| * | |
| Translation |
|
Recalculate
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing | 1145 | |
| EPO | Filing, Examination | 5118 | |
| Japan | Filing | 595 | |
| South Korea | Filing | 574 | |
| USA | Filing, Examination | 2280 |
Total: 9712 USD
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Abstract[English]
Provided are methods and compounds for treating Coronaviridae virus infections by administering avermectin-based bioavailable highly permeable nanocomposites or solid dispersions or aqueous solutions, suspensions or emulsions thereof. The compounds, compositions, and methods provided are particularly useful for the treatment of SARS-CoV-2 virus infection.[French]
L'invention concerne des méthodes et des composés pour traiter des infections par un virus de la famille des Coronaviridae par l'administration de nanocomposites hautement perméables à base d'avermectine ou de dispersions solides ou de solutions aqueuses, de suspensions ou d'émulsions de ceux-ci. Les composés, les compositions et les méthodes décrits sont particulièrement utiles pour le traitement d'une infection par le virus SARS-CoV-2.